WS Dalton

1.7k total citations
23 papers, 1.5k citations indexed

About

WS Dalton is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, WS Dalton has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in WS Dalton's work include Drug Transport and Resistance Mechanisms (15 papers), Cancer therapeutics and mechanisms (7 papers) and Glycosylation and Glycoproteins Research (6 papers). WS Dalton is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Cancer therapeutics and mechanisms (7 papers) and Glycosylation and Glycoproteins Research (6 papers). WS Dalton collaborates with scholars based in United States. WS Dalton's co-authors include TM Grogan, SE Salmon, B W Futscher, DJ Roe, HJ Broxterman, TP Miller, Denise J. Roe, M. Lehnert, Scott S. Emerson and CM Spier and has published in prestigious journals such as Blood, British Journal of Cancer and Journal of Ethnopharmacology.

In The Last Decade

WS Dalton

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by WS Dalton

Since Specialization

Citations

This map shows the geographic impact of WS Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WS Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WS Dalton more than expected).

Fields of papers citing papers by WS Dalton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WS Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WS Dalton. The network helps show where WS Dalton may publish in the future.

Co-authorship network of co-authors of WS Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of WS Dalton. A scholar is included among the top collaborators of WS Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WS Dalton. WS Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of multidrug resistance gene expression in multiple myeloma 1997 ·Leukemia ·WS Dalton	19
2	Clinical cytogenetic correlations in solid tumors 1997 ·Cancer Genetics and Cytogenetics ·Raymond Taetle, Mikel Aickin, (unknown), (unknown), WS Dalton, Siew Hong Leong, Jerry L. Bangert, Anirban Bhattacharyya, Ruth Weinstein, S. E. Salmon, (unknown), J.M. Trent	0
3	Mechanisms of drug resistance in hematologic malignancies. 1997 ·PubMed ·WS Dalton	55
4	Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia 1996 ·Blood ·Alan F. List, (unknown), TM Grogan, Charles A. Johnson, DJ Roe, JP Greer, SN Wolff, HJ Broxterman, G L Scheffer, (unknown), WS Dalton	209
5	Clinical correlations of chromosome abnormalities in human breast, melanoma and ovarian cancer: preliminary analyses of 580 patients 1995 ·Cancer Genetics and Cytogenetics ·Raymond Taetle, (unknown), J.M. Trent, (unknown), Ruth Weinstein, Stanley P. L. Leong, WS Dalton, S. E. Salmon, Denise J. Roe, David S. Alberts	3
6	P-glycoprotein expression and function in circulating blood cells from normal volunteers 1994 ·Blood ·(unknown), B W Futscher, TM Grogan, WS Dalton	299
7	P-glycoprotein expression and function in circulating blood cells from normal volunteers 1994 ·Blood ·(unknown), B W Futscher, TM Grogan, WS Dalton	23
8	P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy 1993 ·Blood ·TM Grogan, CM Spier, SE Salmon, M Matzner, James A. Rybski, (unknown), (unknown), WS Dalton	11
9	P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy 1993 ·Blood ·TM Grogan, CM Spier, SE Salmon, M Matzner, James A. Rybski, (unknown), (unknown), WS Dalton	177
10	Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR. 1992 ·PubMed ·B W Futscher, (unknown), WS Dalton, L. E. Erickson	23
11	Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification 1991 ·British Journal of Cancer ·Paul S. Meltzer, Albert Leibovitz, WS Dalton, Hugo V. Villar, Timothy E. Kute, Joanne Davis, Raymond B. Nagle, Jeffrey M. Trent	47
12	Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer 1991 ·Blood ·SE Salmon, WS Dalton, TM Grogan, (unknown), (unknown), DJ Roe, TP Miller	195
13	Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer 1991 ·Blood ·SE Salmon, WS Dalton, TM Grogan, (unknown), (unknown), DJ Roe, TP Miller	10
14	Cytogenetic findings in 122 cases of breast carcinoma 1991 ·Cancer Genetics and Cytogenetics ·(unknown), (unknown), WS Dalton, Hugo V. Villar, SE Salmon, (unknown)	2
15	Synergistic inhibition by verapamil and quinine of P-glycoprotein- mediated multidrug resistance in a human myeloma cell line model 1991 ·Blood ·M. Lehnert, WS Dalton, Denise J. Roe, Scott S. Emerson, SE Salmon	66
16	Synergistic inhibition by verapamil and quinine of P-glycoprotein- mediated multidrug resistance in a human myeloma cell line model 1991 ·Blood ·M. Lehnert, WS Dalton, Denise J. Roe, Scott S. Emerson, SE Salmon	76
17	Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines 1989 ·Blood ·SE Salmon, B Soehnlen, WS Dalton, Paul S. Meltzer, Philip Scuderi	3
18	Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation 1989 ·Blood ·WS Dalton, TM Grogan, (unknown), (unknown), L Richter, Jenai M. Kailey, HJ Broxterman, H. M. Pinedo, SE Salmon	9
19	Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation 1989 ·Blood ·WS Dalton, TM Grogan, (unknown), (unknown), L Richter, Jenai M. Kailey, HJ Broxterman, H. M. Pinedo, SE Salmon	194
20	Terminal transferase in leukemias by flow cytometry. 1986 ·PubMed ·(unknown), (unknown), WS Dalton, E. M. Hersh, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact